Dr. Larry Kosinski on SonarMD, a Platform for Reducing Hospitalizations in Patients With IBD

Recently, at Digestive Disease Week 2024, SonarMD announced positive results from 2 large, longitudinal studies evaluating several major drivers of medical costs in people living with inflammatory bowel disease (IBD)—defined as ulcerative colitis or Crohn disease—and enrolled in the company’s end-to-end digital care coordination program. In both studies, SonarMD participants experienced a statistically significant and substantial decline in emergency department visits and in-patient admissions compared with risk-matched control groups.

DocWire News spoke with Larry Kosinski, MD, a gastroenterologist and SonarMD founder and board member, to learn more about the company and how its technology can benefit patients with IBD.